• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Successful treatment of refractory heat urticaria with omalizumab.

作者信息

Di Girolamo Attilio, Miniello Andrea, Casella Rossella, Albanesi Marcello, Nettis Eustachio

机构信息

Department of Emergency and Organ Transplantation, School of Allergology and Clinical Immunology, University of Bari Aldo Moro, Policlinico di Bari, Bari, Italy.

Private practice, Centro di Allergologia ed Immunologia Albanesi, Bari, Italy.

出版信息

Postepy Dermatol Alergol. 2024 Aug;41(4):429-431. doi: 10.5114/ada.2024.142183. Epub 2024 Aug 12.

DOI:10.5114/ada.2024.142183
PMID:39290898
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11404098/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd89/11404098/fa7f7d2398b1/PDIA-41-54607-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd89/11404098/fa7f7d2398b1/PDIA-41-54607-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd89/11404098/fa7f7d2398b1/PDIA-41-54607-g001.jpg

相似文献

1
Successful treatment of refractory heat urticaria with omalizumab.奥马珠单抗成功治疗难治性热性荨麻疹。
Postepy Dermatol Alergol. 2024 Aug;41(4):429-431. doi: 10.5114/ada.2024.142183. Epub 2024 Aug 12.
2
Incapacitating solar urticaria: successful treatment with omalizumab.难治性日光性荨麻疹：奥马珠单抗治疗成功
An Bras Dermatol. 2019 Jul 29;94(3):331-333. doi: 10.1590/abd1806-4841.20198109.
3
Omalizumab in the Treatment of Chronic Inducible Urticaria.奥马珠单抗治疗慢性诱导性荨麻疹
Actas Dermosifiliogr. 2017 Jun;108(5):423-431. doi: 10.1016/j.ad.2016.07.018. Epub 2016 Oct 5.
4
Omalizumab in Chronic Spontaneous Urticaria Refractory to Conventional Therapy: An Italian Retrospective Clinical Analysis with Suggestions for Long-Term Maintenance Strategies.奥马珠单抗治疗常规治疗难治性慢性自发性荨麻疹：一项意大利回顾性临床分析及长期维持策略建议
Dermatol Ther (Heidelb). 2018 Jun;8(2):291-301. doi: 10.1007/s13555-018-0240-7. Epub 2018 May 16.
5
Effective treatment of different H1-antihistamine-refractory chronic urticaria phenotypes with omalizumab.奥马珠单抗对不同H1抗组胺药难治性慢性荨麻疹表型的有效治疗。
Turk Pediatri Ars. 2018 Dec 1;53(4):250-254. doi: 10.5152/TurkPediatriArs.2016.4042. eCollection 2018 Dec.
6
Comparison between chronic spontaneous urticaria and chronic induced urticaria on the efficacy of omalizumab treatment: A systematic review and meta-analysis.慢性自发性荨麻疹与慢性诱导性荨麻疹在奥马珠单抗治疗效果方面的比较：系统评价和荟萃分析。
Dermatol Ther. 2022 Dec;35(12):e15928. doi: 10.1111/dth.15928. Epub 2022 Oct 26.
7
Prevalence of omalizumab-resistant chronic urticaria and real-world effectiveness of dupilumab in patients with omalizumab-refractory chronic urticaria: a single-centre experience.奥马珠单抗耐药性慢性荨麻疹的患病率及度普利尤单抗在奥马珠单抗难治性慢性荨麻疹患者中的真实世界疗效：单中心经验
Clin Exp Dermatol. 2024 Sep 18;49(10):1227-1231. doi: 10.1093/ced/llae145.
8
Clinical and laboratory parameters associated with treatment response to third-line therapies in chronic refractory urticaria: A real world study from northern India.与慢性难治性荨麻疹三线治疗反应相关的临床和实验室参数：来自印度北部的真实世界研究。
Dermatol Ther. 2022 Nov;35(11):e15887. doi: 10.1111/dth.15887. Epub 2022 Oct 11.
9
Long term treatment with omalizumab in adolescent with refractory solar urticaria.奥马珠单抗治疗青少年难治性日光性荨麻疹的长期疗效。
Ital J Pediatr. 2021 Sep 28;47(1):195. doi: 10.1186/s13052-021-01151-z.
10
Treatment response to omalizumab in patients with refractory chronic spontaneous urticaria.奥马珠单抗治疗难治性慢性自发性荨麻疹患者的应答。
Int J Dermatol. 2018 Apr;57(4):417-422. doi: 10.1111/ijd.13935. Epub 2018 Feb 5.

本文引用的文献

1
British Association of Dermatologists guidelines for the management of people with chronic urticaria 2021.英国皮肤科医师协会2021年慢性荨麻疹患者管理指南。
Br J Dermatol. 2022 Mar;186(3):398-413. doi: 10.1111/bjd.20892. Epub 2022 Jan 27.
2
Predictors of response to omalizumab and relapse in chronic spontaneous urticaria: a study of 470 patients.奥马珠单抗治疗慢性自发性荨麻疹的疗效预测因子及复发：一项 470 例患者的研究。
J Eur Acad Dermatol Venereol. 2019 May;33(5):918-924. doi: 10.1111/jdv.15350. Epub 2018 Dec 7.
3
Omalizumab in chronic spontaneous urticaria: Efficacy, safety, predictors of treatment outcome, and time to response.
奥马珠单抗治疗慢性自发性荨麻疹：疗效、安全性、治疗结果预测因素和起效时间。
Ann Allergy Asthma Immunol. 2018 Oct;121(4):474-478. doi: 10.1016/j.anai.2018.06.014. Epub 2018 Jun 24.
4
The EAACI/GA²LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria.欧洲过敏研究学会/过敏标准委员会/欧洲皮肤病学会/世界变态反应组织荨麻疹指南：定义、分类、诊断和管理。
Allergy. 2018 Jul;73(7):1393-1414. doi: 10.1111/all.13397.
5
Omalizumab treatment in patients with chronic inducible urticaria: A systematic review of published evidence.奥马珠单抗治疗慢性诱导性荨麻疹患者：已发表证据的系统评价。
J Allergy Clin Immunol. 2018 Feb;141(2):638-649. doi: 10.1016/j.jaci.2017.06.032. Epub 2017 Jul 24.
6
Mechanisms of action that contribute to efficacy of omalizumab in chronic spontaneous urticaria.有助于奥马珠单抗治疗慢性自发性荨麻疹疗效的作用机制。
Allergy. 2017 Apr;72(4):519-533. doi: 10.1111/all.13083. Epub 2017 Jan 4.
7
The definition, diagnostic testing, and management of chronic inducible urticarias - The EAACI/GA(2) LEN/EDF/UNEV consensus recommendations 2016 update and revision.慢性诱导性荨麻疹的定义、诊断检测和管理——EAACI/GA(2)LEN/EDF/UNEV 共识推荐 2016 年更新和修订。
Allergy. 2016 Jun;71(6):780-802. doi: 10.1111/all.12884. Epub 2016 Apr 6.
8
Omalizumab in patients with chronic spontaneous urticaria: a systematic review and GRADE assessment.奥马珠单抗治疗慢性自发性荨麻疹的系统评价和 GRADE 评估。
Br J Dermatol. 2015 Aug;173(2):404-15. doi: 10.1111/bjd.13845. Epub 2015 Jul 22.
9
An improved Peltier effect-based instrument for critical temperature threshold measurement in cold- and heat-induced urticaria.
J Eur Acad Dermatol Venereol. 2015 Oct;29(10):2043-5. doi: 10.1111/jdv.12739. Epub 2014 Sep 30.
10
EAACI taskforce position paper: evidence for autoimmune urticaria and proposal for defining diagnostic criteria.EAACI 工作组立场文件：自身免疫性荨麻疹的证据和诊断标准定义的建议。
Allergy. 2013 Jan;68(1):27-36. doi: 10.1111/all.12056. Epub 2012 Nov 15.